期刊文献+

Effects of two efflux pump inhibitors on the drug susceptibility of Riemerella anatipestifer isolates from China 被引量:3

Effects of two efflux pump inhibitors on the drug susceptibility of Riemerella anatipestifer isolates from China
下载PDF
导出
摘要 The objective of this study was to verify the supposition that efflux might be involved in the drug resistance of Riemerella anatipestifer isolates. Two broad-spectrum effiux pump inhibitors, carbonyl cyanide 3-chlorophenylhydrazone (CCCP) and Phe-Arg-β-naphthylamide (PAL3N), on the contribution of minimum inhibitory concentrations of amikacin, streptomycin, chloramphenicol, tetracycline, ceftdaxone, ceftazidime, nalidixic acid, levofloxacin, enrofloxacin, as well as ciprofloxacin against 69 clinical R. anatipestifer isolates were investigated. We first reported that the two efflux pump inhibitors could restore the antimicrobial susceptibility of R. anatipestiferisolates. It is suggested that active efflux system is possible to be linked with the development of resistance in R. anatipestifer isolates. The objective of this study was to verify the supposition that efflux might be involved in the drug resistance of Riemerella anatipestifer isolates. Two broad-spectrum effiux pump inhibitors, carbonyl cyanide 3-chlorophenylhydrazone (CCCP) and Phe-Arg-β-naphthylamide (PAL3N), on the contribution of minimum inhibitory concentrations of amikacin, streptomycin, chloramphenicol, tetracycline, ceftdaxone, ceftazidime, nalidixic acid, levofloxacin, enrofloxacin, as well as ciprofloxacin against 69 clinical R. anatipestifer isolates were investigated. We first reported that the two efflux pump inhibitors could restore the antimicrobial susceptibility of R. anatipestiferisolates. It is suggested that active efflux system is possible to be linked with the development of resistance in R. anatipestifer isolates.
出处 《Journal of Integrative Agriculture》 SCIE CAS CSCD 2016年第4期929-933,共5页 农业科学学报(英文版)
基金 supported by the Program for Changjiang Scholars and Innovative Research Team in University of Ministry of Education of China (IRT13063) the National Natural Science Foundation of China (31072169)
关键词 Riemerella anatipestifer RESISTANCE EFFLUX CCCP PAI3N Riemerella anatipestifer, resistance, efflux, CCCP, PAI3N
  • 相关文献

参考文献16

  • 1Chen Y P, Lee S H, Chou C H, Tsai H J. 2012. Detection of florfenicol resistance genes in Riemerella anatipestifer isolated from ducks and geese. Veterinary Microbiology, 154, 325-331.
  • 2Chen Y P, Tsao M Y, Lee S H, Chou C H, Tsai H J. 2010. Prevalence and molecular characterization of chloramphenicol resistance in Riemerella anatipestifer isolated from ducks and geese in Taiwan. Avian Pathology, 39, 333-338.
  • 3CLSI (Clinical Laboratory Standards Institute). 2012. Performance standards for antimicrobial susceptibility testing; Twenty-second information supplement. CLSI document. CLSI, Wayne, PA, USA.
  • 4CLSI (Clinical Laboratory Standards Institute). 2013. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals.Approved standard--4th ed. CLSI document VET01-A4 and VET01-S2. CLSI, Wayne, PA, USA.
  • 5Keeney D, Ruzin A, McAteese F, Murphy E, Bradford P A. 2008. MarA-mediated overexpression of the AcrAB efflux pump results in decreased susceptibility to tigecycline in Escherichia coli. Journal of Antimicrobial Chemotherapy, 61.46-53.
  • 6Kothary V, Scherl E J, Bosworth B, Jiang Z D, DuPont H L, Harel J, Simpson KW, Dogan B. 2013. Rifaximin resistance in Escherichia coil associated with inflammatory bowel disease correlates with prior rifaximin use, mutations in rpoB, and activity of Phe-Arg-13-naphthylamide-inhibitable efflux pumps. Antimicrobial Agents and Chemotherapy, 57.811-817.
  • 7Kurincic M, Klancnik A, Smole Mozina S. 2012. Effects of efflux pump inhibitors on erythromycin, ciprofloxacin, and tetracycline resistance in Campylobacter spp. isolates. Microbial Drug Resistance, 18, 492-501.
  • 8Lomovskaya O, Warren M S, Lee A, Galazzo J, Fronko R, Lee M, Blais J, Cho D, Chamberland S, Renau T. 2001. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrobial Agents and Chemotherapy, 45, 105-116.
  • 9Pages J M, Masi M, Barbe J. 2005. Inhibitors of efflux pumps in Gram-negative bacteria. Trends in Molecular Medicine, 11,382-389.
  • 10Pakzad I, Karin M Z, Taherikaiani M, Boustanshenas M, Lari A R. 2013. Contribution of AcrAB efflux pump to ciprofloxacin resistance in Klebsiella pneumoniae isolated from burn patients. GMS Hygiene and Infection Control, 8, 1-6.

同被引文献38

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部